Cancer drug may also be a possible treatment for age-related macular degeneration
intravitreal injections

Cancer drug may also be a possible treatment for age-related macular degeneration

Clinical trials are set to launch later this year to evaluate whether the cancer drug, PRL3-zumab, is effective in treating wet age-related macular degeneration (AMD) as well as diabetic retinopathy.